BENDEKA (BENDAMUSTINE HCI) INJECTION

SECTION 8 & 15-ACCEPTED AND ACKNOWLEDGED

Combined Mark

Key Information

Serial Number

86826918

Registration Number

5014705

Status

Section 8 & 15-accepted and Acknowledged

Ownership

Current Owner

Teva Pharmaceuticals International GmbH

Type: Organization / Corporation

Address

West Chester, PA 19380

Critical Dates

First Use Date

Apr 27, 2016

Filing Date

Nov 20, 2015

Registration Date

Aug 2, 2016

Mark Descriptions

Services

Class 44

Class 044: Providing an interactive website featuring information for health care professionals and patients relating to the treatment of leukemia and lymphoma

Mark Elements

Text Mark

BENDEKA (BENDAMUSTINE HCI) INJECTION

Trademark Timeline

Filing Date

Nov 20, 2015

Publication Date

Mar 8, 2016

First Use

Apr 27, 2016

Registration Date

Aug 2, 2016

USPTO Records

No documents found for this trademark.

Never miss important updates for BENDEKA (BENDAMUSTINE HCI) INJECTION

Get instant alerts when status changes, similar marks are filed, or renewal deadlines approach